Review



directional neural lead for spinal stimulation  (Cordis corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cordis corporation directional neural lead for spinal stimulation
    Illustrations of exemplar technologies in energy-based therapeutic domains: (A) electrical <t>stimulation</t> of vagus nerve ; (B) transcranial magnetic stimulation of brain ; (C) microwave hyperthermia of brain ; (D) optical stimulation of cochlea with near infrared light ; (E) brain stimulation with focused ultrasound (FUS) .
    Directional Neural Lead For Spinal Stimulation, supplied by Cordis corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/directional+neural+lead+for+spinal+stimulation/directional+neural+lead+for+spinal+stimulation/pmc08757806-288-13-5
    Average 90 stars, based on 1 article reviews
    directional neural lead for spinal stimulation - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Technological Improvement Rates and Evolution of Energy-Based Therapeutics"

    Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

    Journal: Frontiers in Medical Technology

    doi: 10.3389/fmedt.2021.714140

    Illustrations of exemplar technologies in energy-based therapeutic domains: (A) electrical stimulation of vagus nerve ; (B) transcranial magnetic stimulation of brain ; (C) microwave hyperthermia of brain ; (D) optical stimulation of cochlea with near infrared light ; (E) brain stimulation with focused ultrasound (FUS) .
    Figure Legend Snippet: Illustrations of exemplar technologies in energy-based therapeutic domains: (A) electrical stimulation of vagus nerve ; (B) transcranial magnetic stimulation of brain ; (C) microwave hyperthermia of brain ; (D) optical stimulation of cochlea with near infrared light ; (E) brain stimulation with focused ultrasound (FUS) .

    Techniques Used:

    Heat map of percentage of common patents between domains. A diagonal cell shows the percentage of patents in a focal domain (e.g., 97.3% for optical stimulation in the fourth row) that are not common with any of the other domains. The off-diagonal cell indicates the percentage of patents in a focal domain common with another domain (e.g., 0.6% for optical stimulation with Microwave/RF stimulation).
    Figure Legend Snippet: Heat map of percentage of common patents between domains. A diagonal cell shows the percentage of patents in a focal domain (e.g., 97.3% for optical stimulation in the fourth row) that are not common with any of the other domains. The off-diagonal cell indicates the percentage of patents in a focal domain common with another domain (e.g., 0.6% for optical stimulation with Microwave/RF stimulation).

    Techniques Used:

    Main paths for the electrical therapeutic domain. E1: A patent cluster for cardiac stimulation for pacing and defibrillation (red box); E2: A patent cluster for neurostimulation (purple box). The blue box shows a subcluster for MRI-compatible leads and electrodes. The patents inside the E1, which are highlighted with red concentric circles, are neuromodulation patents. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.
    Figure Legend Snippet: Main paths for the electrical therapeutic domain. E1: A patent cluster for cardiac stimulation for pacing and defibrillation (red box); E2: A patent cluster for neurostimulation (purple box). The blue box shows a subcluster for MRI-compatible leads and electrodes. The patents inside the E1, which are highlighted with red concentric circles, are neuromodulation patents. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Techniques Used:

    Main paths for the magnetic therapeutic domain. MG1: A patent cluster for stimulation of tissue/bone growth; and MG2: a patent cluster for transcranial brain stimulation. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.
    Figure Legend Snippet: Main paths for the magnetic therapeutic domain. MG1: A patent cluster for stimulation of tissue/bone growth; and MG2: a patent cluster for transcranial brain stimulation. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Techniques Used:

    Main paths for the optical therapeutic domain. OP1: A patent cluster for photochemical stimulation of tissue; OP2: a patent cluster for stimulation of nerves of using light; and OP3: a patent cluster for skin treatment using a laser. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.
    Figure Legend Snippet: Main paths for the optical therapeutic domain. OP1: A patent cluster for photochemical stimulation of tissue; OP2: a patent cluster for stimulation of nerves of using light; and OP3: a patent cluster for skin treatment using a laser. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Techniques Used:

    Main paths for the ultrasound therapeutic domain. US1: A patent cluster for tissue lesioning; US2: bone growth technologies; US3: a patent cluster for wound-healing technologies; and US4: a patent cluster for nerve-stimulation technologies. The table presents node numbers with corresponding patents and their description. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.
    Figure Legend Snippet: Main paths for the ultrasound therapeutic domain. US1: A patent cluster for tissue lesioning; US2: bone growth technologies; US3: a patent cluster for wound-healing technologies; and US4: a patent cluster for nerve-stimulation technologies. The table presents node numbers with corresponding patents and their description. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Techniques Used:

    Related Articles

    other:

    Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics
    Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.



    Similar Products

    directional neural lead for spinal stimulation  (Cordis corporation)
    90
    Cordis corporation directional neural lead for spinal stimulation
    Illustrations of exemplar technologies in energy-based therapeutic domains: (A) electrical <t>stimulation</t> of vagus nerve ; (B) transcranial magnetic stimulation of brain ; (C) microwave hyperthermia of brain ; (D) optical stimulation of cochlea with near infrared light ; (E) brain stimulation with focused ultrasound (FUS) .
    Directional Neural Lead For Spinal Stimulation, supplied by Cordis corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/directional+neural+lead+for+spinal+stimulation/directional+neural+lead+for+spinal+stimulation/pmc08757806-288-13-5
    Average 90 stars, based on 1 article reviews
    directional neural lead for spinal stimulation - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Illustrations of exemplar technologies in energy-based therapeutic domains: (A) electrical stimulation of vagus nerve ; (B) transcranial magnetic stimulation of brain ; (C) microwave hyperthermia of brain ; (D) optical stimulation of cochlea with near infrared light ; (E) brain stimulation with focused ultrasound (FUS) .

    Journal: Frontiers in Medical Technology

    Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

    doi: 10.3389/fmedt.2021.714140

    Figure Lengend Snippet: Illustrations of exemplar technologies in energy-based therapeutic domains: (A) electrical stimulation of vagus nerve ; (B) transcranial magnetic stimulation of brain ; (C) microwave hyperthermia of brain ; (D) optical stimulation of cochlea with near infrared light ; (E) brain stimulation with focused ultrasound (FUS) .

    Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

    Techniques:

    Heat map of percentage of common patents between domains. A diagonal cell shows the percentage of patents in a focal domain (e.g., 97.3% for optical stimulation in the fourth row) that are not common with any of the other domains. The off-diagonal cell indicates the percentage of patents in a focal domain common with another domain (e.g., 0.6% for optical stimulation with Microwave/RF stimulation).

    Journal: Frontiers in Medical Technology

    Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

    doi: 10.3389/fmedt.2021.714140

    Figure Lengend Snippet: Heat map of percentage of common patents between domains. A diagonal cell shows the percentage of patents in a focal domain (e.g., 97.3% for optical stimulation in the fourth row) that are not common with any of the other domains. The off-diagonal cell indicates the percentage of patents in a focal domain common with another domain (e.g., 0.6% for optical stimulation with Microwave/RF stimulation).

    Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

    Techniques:

    Main paths for the electrical therapeutic domain. E1: A patent cluster for cardiac stimulation for pacing and defibrillation (red box); E2: A patent cluster for neurostimulation (purple box). The blue box shows a subcluster for MRI-compatible leads and electrodes. The patents inside the E1, which are highlighted with red concentric circles, are neuromodulation patents. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Journal: Frontiers in Medical Technology

    Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

    doi: 10.3389/fmedt.2021.714140

    Figure Lengend Snippet: Main paths for the electrical therapeutic domain. E1: A patent cluster for cardiac stimulation for pacing and defibrillation (red box); E2: A patent cluster for neurostimulation (purple box). The blue box shows a subcluster for MRI-compatible leads and electrodes. The patents inside the E1, which are highlighted with red concentric circles, are neuromodulation patents. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

    Techniques:

    Main paths for the magnetic therapeutic domain. MG1: A patent cluster for stimulation of tissue/bone growth; and MG2: a patent cluster for transcranial brain stimulation. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Journal: Frontiers in Medical Technology

    Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

    doi: 10.3389/fmedt.2021.714140

    Figure Lengend Snippet: Main paths for the magnetic therapeutic domain. MG1: A patent cluster for stimulation of tissue/bone growth; and MG2: a patent cluster for transcranial brain stimulation. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

    Techniques:

    Main paths for the optical therapeutic domain. OP1: A patent cluster for photochemical stimulation of tissue; OP2: a patent cluster for stimulation of nerves of using light; and OP3: a patent cluster for skin treatment using a laser. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Journal: Frontiers in Medical Technology

    Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

    doi: 10.3389/fmedt.2021.714140

    Figure Lengend Snippet: Main paths for the optical therapeutic domain. OP1: A patent cluster for photochemical stimulation of tissue; OP2: a patent cluster for stimulation of nerves of using light; and OP3: a patent cluster for skin treatment using a laser. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

    Techniques:

    Main paths for the ultrasound therapeutic domain. US1: A patent cluster for tissue lesioning; US2: bone growth technologies; US3: a patent cluster for wound-healing technologies; and US4: a patent cluster for nerve-stimulation technologies. The table presents node numbers with corresponding patents and their description. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Journal: Frontiers in Medical Technology

    Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

    doi: 10.3389/fmedt.2021.714140

    Figure Lengend Snippet: Main paths for the ultrasound therapeutic domain. US1: A patent cluster for tissue lesioning; US2: bone growth technologies; US3: a patent cluster for wound-healing technologies; and US4: a patent cluster for nerve-stimulation technologies. The table presents node numbers with corresponding patents and their description. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

    Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

    Techniques: